Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ilan Asher

Showing results (11-20 of 60) with videos related to

Pageof 6
Sort By:
Harefuah|April 23, 2005
[Opsoclonus myoclonus with ataxia]Ilan Asher, Daniel Elbirt, M Kushnir, et al.
Clinics in Dermatology|June 15, 2010
The management of systemic lupus erythematosus: Facts and controversiesDaniel Elbirt, Dalia Sthoeger, Ilan Asher, et al.
The Israel Medical Association Journal : IMAJ|September 18, 2012
Novel biological treatments for systemic lupus erythematosus: current and future modalitiesShira Bezalel, Ilan Asher, Daniel Elbirt, et al.
The Israel Medical Association Journal : IMAJ|November 13, 2024
Allergic Rhinitis in Israel: A Multicenter Study of Allergic Rhinitis Across Three Climate ZonesRachel Eisenberg, Allon Raphael, Matan Risling, et al.
Clinical Immunology (Orlando, Fla.)|September 1, 2018
Indoleamine-2,3-dioxygenase in murine and human systemic lupus erythematosus: Down-regulation by the tolerogeneic peptide hCDR1Zev Sthoeger, Amir Sharabi, Heidy Zinger, et al.
The Israel Medical Association Journal : IMAJ|December 1, 2012
Immunoglobulin G4 and related diseasesZev Sthoeger, Ilan Asher, Shira Rosenberg-Bezalel, et al.
Plos One|April 5, 2013
The tolerogenic peptide, hCDR1, down-regulates the expression of interferon-α in murine and human systemic lupus erythematosusZev Sthoeger, Heidy Zinger, Amir Sharabi, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|June 27, 2022
Early childhood allergy linked with development of attention deficit hyperactivity disorder and autism spectrum disorderShay Nemet, Ilan Asher, Israel Yoles, et al.
Immunology|February 5, 2009
High alpha-defensin levels in patients with systemic lupus erythematosusZev M Sthoeger, Shira Bezalel, Nava Chapnik, et al.
The Israel Medical Association Journal : IMAJ|July 24, 2007
The beneficial effects of Xolair (omalizumab) as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available treatment (GINA 2002 step IV)--the Israeli arm of the INNOVATE studyZev M Sthoeger, Abraham Eliraz, Ilan Asher, et al.
Pageof 6

Showing results (11-20 of 60) with videos related to

Sort By:
Pageof 6
Harefuah|April 23, 2005
[Opsoclonus myoclonus with ataxia]Ilan Asher, Daniel Elbirt, M Kushnir, et al.
Clinics in Dermatology|June 15, 2010
The management of systemic lupus erythematosus: Facts and controversiesDaniel Elbirt, Dalia Sthoeger, Ilan Asher, et al.
The Israel Medical Association Journal : IMAJ|September 18, 2012
Novel biological treatments for systemic lupus erythematosus: current and future modalitiesShira Bezalel, Ilan Asher, Daniel Elbirt, et al.
The Israel Medical Association Journal : IMAJ|November 13, 2024
Allergic Rhinitis in Israel: A Multicenter Study of Allergic Rhinitis Across Three Climate ZonesRachel Eisenberg, Allon Raphael, Matan Risling, et al.
Clinical Immunology (Orlando, Fla.)|September 1, 2018
Indoleamine-2,3-dioxygenase in murine and human systemic lupus erythematosus: Down-regulation by the tolerogeneic peptide hCDR1Zev Sthoeger, Amir Sharabi, Heidy Zinger, et al.
The Israel Medical Association Journal : IMAJ|December 1, 2012
Immunoglobulin G4 and related diseasesZev Sthoeger, Ilan Asher, Shira Rosenberg-Bezalel, et al.
Plos One|April 5, 2013
The tolerogenic peptide, hCDR1, down-regulates the expression of interferon-α in murine and human systemic lupus erythematosusZev Sthoeger, Heidy Zinger, Amir Sharabi, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|June 27, 2022
Early childhood allergy linked with development of attention deficit hyperactivity disorder and autism spectrum disorderShay Nemet, Ilan Asher, Israel Yoles, et al.
Immunology|February 5, 2009
High alpha-defensin levels in patients with systemic lupus erythematosusZev M Sthoeger, Shira Bezalel, Nava Chapnik, et al.
The Israel Medical Association Journal : IMAJ|July 24, 2007
The beneficial effects of Xolair (omalizumab) as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available treatment (GINA 2002 step IV)--the Israeli arm of the INNOVATE studyZev M Sthoeger, Abraham Eliraz, Ilan Asher, et al.
Pageof 6